Treatment of rheumatoid arthritis with imatinib mesylate: clinical improvement in three refractory cases [PDF]
, 2003 Kari K. Eklund, Heikki Joensuu
openalex +1 more source
Imatinib Mesylate for the Treatment of Canine Mast Cell Tumors: Assessment of the Response and Adverse Events in Comparison with the Conventional Therapy with Vinblastine and Prednisone. [PDF]
Cells, 2022 Macedo TR +9 more
europepmc +1 more source
Fluorescence in situ hybridization for the BCR–ABL fusion gene in a patient with imatinib mesylate‐resistant chronic myelogenous leukaemia in extramedullary blast crisis [PDF]
, 2003 Takehiko Mori +3 more
openalex +1 more source
Imatinib mesylate inhibits the profibrogenic activity of TGF-β and prevents bleomycin-mediated lung fibrosis [PDF]
, 2004 Craig Daniels +6 more
openalex +2 more sources
In vivo Pharmacokinetics and in vitro Release of Imatinib Mesylate-Loaded Liposomes for Pulmonary Delivery. [PDF]
Int J Nanomedicine, 2021 Xu H +5 more
europepmc +1 more source
Imatinib mesylate elicits positive clinical response in atypical chronic myeloid leukemia involving the platelet-derived growth factor receptor beta [PDF]
, 2003 Juan Luis Garcı́a +6 more
openalex +1 more source
Imatinib Mesylate-Induced Acquired Dermal Melanocytosis and Acquired Bilateral Nevus of Ota-Like Macules. [PDF]
Ann Dermatol, 2021 Jang JW +6 more
europepmc +1 more source
Molecular response to imatinib mesylate following relapse after allogeneic SCT for CML [PDF]
, 2003 Shaun R. McCann +3 more
openalex +1 more source
In Vivo Efficacy of Imatinib Mesylate, a Tyrosine Kinase Inhibitor, in the Treatment of Chemically Induced Dry Eye in Animal Models. [PDF]
Transl Vis Sci Technol, 2021 Baek YY +6 more
europepmc +1 more source
Imatinib mesylate in combination with pembrolizumab in patients with advanced KIT-mutant melanoma following progression on standard therapy: A phase I/II trial and study protocol. [PDF]
Medicine (Baltimore), 2021 Hirai I +7 more
europepmc +1 more source